1 694 142 EFFECT OF EISCHENS YOGA DURING RADIATION THERAPY ON PROSTATE CANCER PATIENT SYMPTOMS AND QUALITY OF LIFE: A RANDOMIZED PHASE II TRIAL. PURPOSE: A RANDOMIZED PHASE II STUDY WAS PERFORMED TO MEASURE THE POTENTIAL THERAPEUTIC EFFECTS OF YOGA ON FATIGUE, ERECTILE DYSFUNCTION, URINARY INCONTINENCE, AND OVERALL QUALITY OF LIFE (QOL) IN PROSTATE CANCER (PCA) PATIENTS UNDERGOING EXTERNAL BEAM RADIATION THERAPY (RT). METHODS AND MATERIALS: THE PARTICIPANTS WERE RANDOMIZED TO YOGA AND NO-YOGA COHORTS (1:1). TWICE-WEEKLY YOGA INTERVENTIONS WERE OFFERED THROUGHOUT THE 6- TO 9-WEEK COURSES OF RT. COMPARISONS OF STANDARDIZED ASSESSMENTS WERE PERFORMED BETWEEN THE 2 COHORTS FOR THE PRIMARY ENDPOINT OF FATIGUE AND THE SECONDARY ENDPOINTS OF ERECTILE DYSFUNCTION, URINARY INCONTINENCE, AND QOL BEFORE, DURING, AND AFTER RT. RESULTS: FROM OCTOBER 2014 TO JANUARY 2016, 68 ELIGIBLE PCA PATIENTS UNDERWENT INFORMED CONSENT AND AGREED TO PARTICIPATE IN THE STUDY. OF THE 68 PATIENTS, 18 WITHDREW EARLY, MOSTLY BECAUSE OF TREATMENT SCHEDULE-RELATED TIME CONSTRAINTS, RESULTING IN 22 AND 28 PATIENTS IN THE YOGA AND NO-YOGA GROUPS, RESPECTIVELY. THROUGHOUT TREATMENT, THOSE IN THE YOGA ARM REPORTED LESS FATIGUE THAN THOSE IN THE CONTROL ARM, WITH GLOBAL FATIGUE, EFFECT OF FATIGUE, AND SEVERITY OF FATIGUE SUBSCALES SHOWING STATISTICALLY SIGNIFICANT INTERACTIONS (P<.0001). THE SEXUAL HEALTH SCORES (INTERNATIONAL INDEX OF ERECTILE FUNCTION QUESTIONNAIRE) ALSO DISPLAYED A STATISTICALLY SIGNIFICANT INTERACTION (P=.0333). THE INTERNATIONAL PROSTATE SYMPTOM SCORE REVEALED A STATISTICALLY SIGNIFICANT EFFECT OF TIME (P<.0001) BUT NO SIGNIFICANT EFFECT OF TREATMENT (P=.1022). THE QOL MEASURES HAD MIXED RESULTS, WITH YOGA HAVING A SIGNIFICANT TIME BY TREATMENT EFFECT ON THE EMOTIONAL, PHYSICAL, AND SOCIAL SCORES BUT NOT ON FUNCTIONAL SCORES. CONCLUSIONS: A STRUCTURED YOGA INTERVENTION OF TWICE-WEEKLY CLASSES DURING A COURSE OF RT WAS ASSOCIATED WITH A SIGNIFICANT REDUCTION IN PRE-EXISTING AND RT-RELATED FATIGUE AND URINARY AND SEXUAL DYSFUNCTION IN PCA PATIENTS. 2017 2 2701 70 YOGA INTERVENTION FOR PATIENTS WITH PROSTATE CANCER UNDERGOING EXTERNAL BEAM RADIATION THERAPY: A PILOT FEASIBILITY STUDY. PURPOSE: STUDIES HAVE DEMONSTRATED BENEFICIAL HEALTH EFFECTS FROM YOGA INTERVENTIONS IN CANCER PATIENTS, BUT PREDOMINANTLY IN BREAST CANCER. RESEARCH ON ITS ROLE IN ALLEVIATING PROSTATE CANCER (PC) PATIENTS' SIDE EFFECTS HAS BEEN LACKING. OUR PRIMARY GOAL WAS TO DETERMINE THE FEASIBILITY OF RECRUITING PC PATIENTS ON A CLINICAL TRIAL OF YOGA WHILE THEY UNDERWENT EXTERNAL BEAM RADIATION THERAPY (RT). METHODS: TWICE-WEEKLY YOGA INTERVENTIONS WERE OFFERED THROUGHOUT THE RT COURSE (6-9 WEEKS). BASELINE DEMOGRAPHIC INFORMATION WAS COLLECTED. FEASIBILITY WAS DECLARED IF 15 OF THE FIRST 75 ELIGIBLE PC PATIENTS APPROACHED (20%) WERE SUCCESSFULLY ACCRUED AND COMPLETED THE INTERVENTION. ADDITIONAL END POINTS INCLUDED STANDARDIZED ASSESSMENTS OF FATIGUE, ERECTILE DYSFUNCTION (ED), URINARY INCONTINENCE (UI), AND QUALITY OF LIFE (QOL) AT TIME POINTS BEFORE, DURING, AND AFTER RT. RESULTS: BETWEEN MAY 2013 AND JUNE 2014, 68 ELIGIBLE PC PATIENTS WERE IDENTIFIED. 23 PATIENTS (34%) DECLINED, AND 45 (56%) CONSENTED TO THE STUDY. 18 (40%) WERE VOLUNTARILY WITHDRAWN DUE TO TREATMENT CONFLICTS. OF THE REMAINING 27, 12 (30%) PARTICIPATED IN >/=50% OF CLASSES, AND 15 (59%) WERE EVALUABLE. SEVERITY OF FATIGUE SCORES DEMONSTRATED SIGNIFICANT VARIABILITY, WITH FATIGUE INCREASING BY WEEK 4, BUT THEN IMPROVING OVER THE COURSE OF TREATMENT (P = .008). ED, UI, AND GENERAL QOL SCORES DEMONSTRATED REASSURINGLY STABLE, ALBEIT NOT SIGNIFICANT TRENDS. CONCLUSIONS: A STRUCTURED YOGA INTERVENTION OF TWICE-WEEKLY CLASSES IS FEASIBLE FOR PC PATIENTS DURING A 6- TO 9-WEEK COURSE OF OUTPATIENT RADIOTHERAPY. PRELIMINARY RESULTS ARE PROMISING, SHOWING STABLE MEASUREMENTS IN FATIGUE, SEXUAL HEALTH, UI, AND GENERAL QOL. 2016 3 974 48 EFFECTS OF AN INTEGRATED YOGA PROGRAM ON SELF-REPORTED DEPRESSION SCORES IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT: A RANDOMIZED CONTROLLED TRIAL. AIM: TO COMPARE THE EFFECTS OF YOGA PROGRAM WITH SUPPORTIVE THERAPY ON SELF-REPORTED SYMPTOMS OF DEPRESSION IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT. PATIENTS AND METHODS: NINETY-EIGHT BREAST CANCER PATIENTS WITH STAGE II AND III DISEASE FROM A CANCER CENTER WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 45) AND SUPPORTIVE THERAPY (N = 53) OVER A 24-WEEK PERIOD DURING WHICH THEY UNDERWENT SURGERY FOLLOWED BY ADJUVANT RADIOTHERAPY (RT) OR CHEMOTHERAPY (CT) OR BOTH. THE STUDY STOPPAGE CRITERIA WAS PROGRESSIVE DISEASE RENDERING THE PATIENT BEDRIDDEN OR ANY PHYSICAL MUSCULOSKELETAL INJURY RESULTING FROM INTERVENTION OR LESS THAN 60% ATTENDANCE TO YOGA INTERVENTION. SUBJECTS UNDERWENT YOGA INTERVENTION FOR 60 MIN DAILY WITH CONTROL GROUP UNDERGOING SUPPORTIVE THERAPY DURING THEIR HOSPITAL VISITS. BECK'S DEPRESSION INVENTORY (BDI) AND SYMPTOM CHECKLIST WERE ASSESSED AT BASELINE, AFTER SURGERY, BEFORE, DURING, AND AFTER RT AND SIX CYCLES OF CT. WE USED ANALYSIS OF COVARIANCE (INTENT-TO-TREAT) TO STUDY THE EFFECTS OF INTERVENTION ON DEPRESSION SCORES AND PEARSON CORRELATION ANALYSES TO EVALUATE THE BIVARIATE RELATIONSHIPS. RESULTS: A TOTAL OF 69 PARTICIPANTS CONTRIBUTED DATA TO THE CURRENT ANALYSIS (YOGA, N = 33, AND CONTROLS, N = 36). THERE WAS 29% ATTRITION IN THIS STUDY. THE RESULTS SUGGEST AN OVERALL DECREASE IN SELF-REPORTED DEPRESSION WITH TIME IN BOTH THE GROUPS. THERE WAS A SIGNIFICANT DECREASE IN DEPRESSION SCORES IN THE YOGA GROUP AS COMPARED TO CONTROLS FOLLOWING SURGERY, RT, AND CT (P < 0.01). THERE WAS A POSITIVE CORRELATION (P < 0.001) BETWEEN DEPRESSION SCORES WITH SYMPTOM SEVERITY AND DISTRESS DURING SURGERY, RT, AND CT. CONCLUSION: THE RESULTS SUGGEST POSSIBLE ANTIDEPRESSANT EFFECTS WITH YOGA INTERVENTION IN BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT. 2015 4 2644 35 YOGA FOR WOMEN WITH URGENCY URINARY INCONTINENCE: A PILOT STUDY. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE THE FEASIBILITY OF A GENTLE YOGA PROGRAM FOR WOMEN WITH URGENCY URINARY INCONTINENCE (UUI). ALSO, THESE PRELIMINARY DATA CAN EVALUATE IF YOGA IMPROVES SYMPTOM BURDEN, QUALITY OF LIFE, AND INFLAMMATORY BIOMARKERS FOR WOMEN WITH UUI. METHODS: THIS PROSPECTIVE NONRANDOMIZED SINGLE-ARM PILOT STUDY EVALUATED THE EFFECTIVENESS OF A TWICE-WEEKLY, 8-WEEK GENTLE YOGA INTERVENTION TO REDUCE UUI SYMPTOM BURDEN. CHANGES IN SYMPTOM BURDEN WERE MEASURED USING THE PELVIC FLOOR DISTRESS INVENTORY 20. SECONDARY MEASURES INCLUDED QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, SLEEP, STRESS, ANXIETY, AND INFLAMMATORY BIOMARKERS. OUTCOMES WERE EVALUATED WITH PAIRED T TESTING. RESULTS: TWELVE WOMEN COMPLETED THE YOGA INTERVENTION WITH NO ADVERSE OUTCOMES NOTED. URGENCY SYMPTOM BURDEN WAS SIGNIFICANTLY IMPROVED AFTER THE INTERVENTION (P = 0.01), AND WOMEN REPORTED AN INCREASE IN QUALITY OF LIFE (P = 0.04) AFTER THE YOGA INTERVENTION. FOLLOWING THE YOGA INTERVENTION, THE MAJORITY OF WOMEN REPORTED SYMPTOMS AS "MUCH BETTER" (N = 4 [33%]) AND "A LITTLE BETTER" (N = 5 [42%]), WITH 3 WOMEN (25%) REPORTING "NO CHANGE." WOMEN ALSO REPORTED SIGNIFICANT REDUCTION IN DEPRESSIVE SYMPTOMS (P = 0.03) AND BETTER QUALITY OF SLEEP (P = 0.03). NO SIGNIFICANT CHANGES WERE FOUND IN ANXIETY OR STRESS PERCEPTION. PLASMA LEVELS OF THE INFLAMMATORY BIOMARKER TUMOR NECROSIS FACTOR ALPHA WERE REDUCED AFTER YOGA INTERVENTION (P = 0.009); HOWEVER, NO SIGNIFICANT POSTYOGA CHANGES WERE FOUND FOR INTERLEUKIN 6 OR C-REACTIVE PROTEIN. CONCLUSIONS: THIS STUDY PROVIDES PRELIMINARY EVIDENCE THAT YOGA IS A FEASIBLE COMPLEMENTARY THERAPY THAT REDUCES INCONTINENCE SYMPTOM BURDEN, ALONG WITH IMPROVING QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, AND SLEEP QUALITY. ADDITIONALLY, YOGA MAY LOWER INFLAMMATORY BIOMARKERS ASSOCIATED WITH INCONTINENCE. 2021 5 2096 42 THE EFFECT OF YOGA EXERCISE ON IMPROVING DEPRESSION, ANXIETY, AND FATIGUE IN WOMEN WITH BREAST CANCER: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DEPRESSION, ANXIETY, AND FATIGUE ARE AMONG THE MOST SIGNIFICANT PROBLEMS THAT INFLUENCE THE QUALITY OF LIFE OF PATIENTS WITH BREAST CANCER WHO RECEIVE ADJUVANT CHEMOTHERAPY. ALTHOUGH EVIDENCE HAS SHOWN YOGA TO DECREASE ANXIETY, DEPRESSION, AND FATIGUE IN PATIENTS WITH CANCER, FEW STUDIES ON THE EFFECTS OF YOGA HAVE TARGETED PATIENTS WITH BREAST CANCER. YOGA INTERVENTIONS SHOULD BE TESTED TO PROMOTE THE PSYCHOLOGICAL AND PHYSICAL HEALTH OF WOMEN WITH BREAST CANCER. PURPOSE: THIS STUDY EXAMINES THE EFFECTIVENESS OF AN 8-WEEK YOGA EXERCISE PROGRAM IN PROMOTING THE PSYCHOLOGICAL AND PHYSICAL HEALTH OF WOMEN WITH BREAST CANCER UNDERGOING ADJUVANT CHEMOTHERAPY IN TERMS OF DEPRESSION, ANXIETY, AND FATIGUE. METHODS: A SAMPLE OF 60 WOMEN WITH NONMETASTATIC BREAST CANCER WAS RECRUITED. PARTICIPANTS WERE RANDOMLY ASSIGNED INTO EITHER THE EXPERIMENTAL GROUP (N = 30) OR THE CONTROL GROUP (N = 30). A 60-MINUTE, TWICE-PER-WEEK YOGA EXERCISE WAS IMPLEMENTED FOR 8 WEEKS AS THE INTERVENTION FOR THE PARTICIPANTS IN THE EXPERIMENTAL GROUP. THE CONTROL GROUP RECEIVED STANDARD CARE ONLY. RESULTS: ANALYSIS USING THE JOHNSON-NEYMAN PROCEDURE FOUND THAT THE YOGA EXERCISE REDUCED OVERALL FATIGUE AND THE INTERFERENCE OF FATIGUE IN EVERYDAY LIFE FOR THE EXPERIMENTAL GROUP PARTICIPANTS. SIGNIFICANT REDUCTIONS WERE OBTAINED AFTER 4 WEEKS OF INTERVENTION PARTICIPATION FOR THOSE EXPERIMENTAL GROUP PATIENTS WITH RELATIVELY LOW STARTING BASELINE VALUES (BASELINE ITEM MEAN VALUE < 3.31 AND 3.22, RESPECTIVELY) AND AFTER 8 WEEKS FOR MOST PATIENTS (APPROXIMATELY 75%) WITH MODERATE STARTING BASELINE VALUES (BASELINE ITEM MEAN VALUE < 7.30 AND 5.34, RESPECTIVELY). THE 8-WEEK INTERVENTION DID NOT SIGNIFICANTLY IMPROVE THE LEVELS OF DEPRESSION (F = 1.29, P > .05) OR ANXIETY (F = 2.7, P > .05). CONCLUSIONS/IMPLICATIONS FOR PRACTICE: THE 8-WEEK YOGA EXERCISE PROGRAM DEVELOPED IN THIS STUDY EFFECTIVELY REDUCED FATIGUE IN PATIENTS WITH BREAST CANCER BUT DID NOT REDUCE DEPRESSION OR ANXIETY. ONCOLOGY NURSES SHOULD STRENGTHEN THEIR CLINICAL HEALTH EDUCATION AND APPLY YOGA TO REDUCE THE FATIGUE EXPERIENCED BY PATIENTS WITH BREAST CANCER WHO UNDERGO ADJUVANT CHEMOTHERAPY. 2014 6 428 39 CAN YOGA HAVE ANY EFFECT ON SHOULDER AND ARM PAIN AND QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER? A RANDOMIZED, CONTROLLED, SINGLE-BLIND TRIAL. OBJECTIVE: TO EXAMINE THE EFFECTS OF YOGA ON SHOULDER AND ARM PAIN, QUALITY OF LIFE (QOL), DEPRESSION, AND PHYSICAL PERFORMANCE IN PATIENTS WITH BREAST CANCER. METHODS: THIS PROSPECTIVE, RANDOMIZED STUDY INCLUDED 42 PATIENTS. THE PATIENTS IN GROUP 1 UNDERWENT A 10-WEEK HATHA YOGA EXERCISE PROGRAM. THE PATIENTS IN GROUP 2 WERE INCLUDED IN A 10-WEEK FOLLOW-UP PROGRAM. OUR PRIMARY ENDPOINT WAS ARM AND SHOULDER PAIN INTENSITY. RESULTS: THE GROUP RECEIVING YOGA SHOWED A SIGNIFICANT IMPROVEMENT IN THEIR PAIN SEVERITY FROM BASELINE TO POST-TREATMENT, AND THESE BENEFITS WERE MAINTAINED AT 2.5 MONTHS POST-TREATMENT. WHEN COMPARED TO THE CONTROL GROUP, THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE 2 GROUPS WITH RESPECT TO THE PARAMETERS ASSESSED AT THE END OF WEEK 10. CONCLUSION: YOGA WAS AN EFFECTIVE AND SAFE EXERCISE FOR ALLEVIATING SHOULDER AND ARM PAIN, WHICH IS A COMPLICATION WITH A HIGH PREVALENCE IN PATIENTS WITH BREAST CANCER. 2018 7 2508 47 YOGA BREATHING FOR CANCER CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE: RESULTS OF A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: MANY DEBILITATING SYMPTOMS ARISE FROM CANCER AND ITS TREATMENT THAT ARE OFTEN UNRELIEVED BY ESTABLISHED METHODS. PRANAYAMA, A SERIES OF YOGIC BREATHING TECHNIQUES, MAY IMPROVE CANCER-RELATED SYMPTOMS AND QUALITY OF LIFE, BUT IT HAS NOT BEEN STUDIED FOR THIS PURPOSE. OBJECTIVES: A PILOT STUDY WAS PERFORMED TO EVALUATE FEASIBILITY AND TO TEST THE EFFECTS OF PRANAYAMA ON CANCER-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. DESIGN: THIS WAS A RANDOMIZED CONTROLLED CLINICAL TRIAL COMPARING PRANAYAMA TO USUAL CARE. SETTING: THE STUDY WAS CONDUCTED AT A UNIVERSITY MEDICAL CENTER. SUBJECTS: PATIENTS RECEIVING CANCER CHEMOTHERAPY WERE RANDOMIZED TO RECEIVE PRANAYAMA IMMEDIATELY OR AFTER A WAITING PERIOD (CONTROL GROUP). INTERVENTIONS: THE PRANAYAMA INTERVENTION CONSISTED OF FOUR BREATHING TECHNIQUES TAUGHT IN WEEKLY CLASSES AND PRACTICED AT HOME. THE TREATMENT GROUP RECEIVED PRANAYAMA DURING TWO CONSECUTIVE CYCLES OF CHEMOTHERAPY. THE CONTROL GROUP RECEIVED USUAL CARE DURING THEIR FIRST CYCLE, AND RECEIVED PRANAYAMA DURING THEIR SECOND CYCLE OF CHEMOTHERAPY. OUTCOME MEASURES: FEASIBILITY, CANCER-ASSOCIATED SYMPTOMS (FATIGUE, SLEEP DISTURBANCE, ANXIETY, DEPRESSION, STRESS), AND QUALITY OF LIFE WERE THE OUTCOMES. RESULTS: CLASS ATTENDANCE WAS NEARLY 100% IN BOTH GROUPS. SIXTEEN (16) PARTICIPANTS WERE INCLUDED IN THE FINAL INTENT-TO-TREAT ANALYSES. THE REPEATED-MEASURES ANALYSES DEMONSTRATED THAT ANY INCREASE IN PRANAYAMA DOSE, WITH DOSE MEASURED IN THE NUMBER OF HOURS PRACTICED IN CLASS OR AT HOME, RESULTED IN IMPROVED SYMPTOM AND QUALITY-OF-LIFE SCORES. SEVERAL OF THESE ASSOCIATIONS--SLEEP DISTURBANCE (P=0.04), ANXIETY (P=0.04), AND MENTAL QUALITY OF LIFE (P=0.05)--REACHED OR APPROACHED STATISTICAL SIGNIFICANCE. CONCLUSIONS: YOGA BREATHING WAS A FEASIBLE INTERVENTION AMONG PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY. PRANAYAMA MAY IMPROVE SLEEP DISTURBANCE, ANXIETY, AND MENTAL QUALITY OF LIFE. A DOSE-RESPONSE RELATIONSHIP WAS FOUND BETWEEN PRANAYAMA USE AND IMPROVEMENTS IN CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. THESE FINDINGS NEED TO BE CONFIRMED IN A LARGER STUDY. 2012 8 2883 30 YOGA: A TOOL FOR IMPROVING THE QUALITY OF LIFE IN CHRONIC PANCREATITIS. AIM: TO DETERMINE THE EFFECTIVENESS OF YOGA ON IMPROVING THE QUALITY OF LIFE IN PATIENTS OF CHRONIC PANCREATITIS. METHODS: THE PATIENTS WERE RANDOMIZED TO TWO GROUPS. THE CONTROL GROUP CONTINUED THEIR USUAL CARE AS DIRECTED BY THEIR PHYSICIANS. PATIENTS IN THE YOGA GROUP, IN ADDITION, RECEIVED BIWEEKLY YOGA SESSIONS FOR 12 WK. THE PATIENTS' DEMOGRAPHIC AND HEALTH BEHAVIOUR VARIABLES WERE ASSESSED BEFORE AND AFTER THE YOGA PROGRAMME USING MEDICAL OUTCOMES SHORT FORM (SF-36) FOR QUALITY OF LIFE, PROFILE OF MOOD STATES FOR ASSESSING MOOD AND SYMPTOMS OF STRESS INVENTORY FOR MEASURING STRESS. RESULTS: A TOTAL OF 60 PATIENTS WERE ENROLLED, WITH 8 DROP-OUTS. THIRTY PATIENTS WERE RANDOMIZED TO THE YOGA GROUP AND 30 TO THE CONTROL GROUP. SIGNIFICANT IMPROVEMENTS WERE SEEN IN OVERALL QUALITY OF LIFE, SYMPTOMS OF STRESS, MOOD CHANGES, ALCOHOL DEPENDENCE AND APPETITE AFTER THE 12 WK PERIOD APART FROM THE GENERAL FEELING OF WELL-BEING AND DESIRE TO CONTINUE WITH THE PROGRAMME IN FUTURE IN THE YOGA GROUP, WHILE THERE WAS NO DIFFERENCE IN THE CONTROL GROUP. CONCLUSION: YOGA IS EFFECTIVE ON IMPROVING THE QUALITY OF LIFE IN PATIENTS OF CHRONIC PANCREATITIS. 2007 9 1380 36 IMPACT OF LONG TERM YOGA PRACTICE ON SLEEP QUALITY AND QUALITY OF LIFE IN THE ELDERLY. BACKGROUND: SLEEP DISTURBANCES AND DECLINE IN THE PHYSICAL FUNCTIONALITY ARE COMMON CONDITIONS ASSOCIATED WITH AGING. PHARMACOLOGICAL TREATMENT OF SLEEP DISTURBANCES CAN BE ASSOCIATED WITH VARIOUS ADVERSE EFFECTS. SHORT TERM TRIALS OF YOGA ON SLEEP HAVE SHOWN BENEFICIAL EFFECTS. OBJECTIVES: TO EVALUATE THE EFFECT OF LONG-TERM YOGA EXERCISES ON SLEEP QUALITY AND QUALITY OF LIFE (QOL) IN THE ELDERLY. MATERIALS AND METHODS: THIS WAS A CROSS-SECTIONAL STUDY IN WHICH DATA WERE COLLECTED FROM ELDERLY PEOPLE AGED 60 YEARS OR MORE LIVING IN NAGPUR CITY. WE EMPLOYED TWO TYPES OF SURVEY QUESTIONNAIRES: PITTSBURGH SLEEP QUALITY INDEX (PSQI) AND QOL LEIDEN-PADUA (LEIPAD) QUESTIONNAIRE. A TOTAL OF 65 ELDERLY MEN AND WOMEN WHO SIGNED AN INFORMED CONSENT AND COMPLETED QUESTIONNAIRES WERE INCLUDED IN THE STUDY. SLEEP QUALITY SCORE PSQI AND QOL (LEIPAD QUESTIONNAIRE) SCORE OF THE STUDY GROUP WERE EVALUATED AND COMPARED WITH THE CONTROL GROUP USING MANN-WHITNEY U TEST. RESULTS: TOTAL PSQI SCORE IN YOGA GROUP WAS LOWER THAN THAT OF THE CONTROL GROUP. ALSO VARIOUS QOL SCORES OF THE YOGA GROUPS WERE HIGHER THAN THE CONTROL GROUP. CONCLUSION: ADDITION OF REGULAR YOGA EXERCISES IN THE DAILY ROUTINE OF ELDERLY PEOPLE CAN HELP TO ACHIEVE GOOD SLEEP QUALITY AS WELL AS IMPROVE THE QOL. 2013 10 1731 40 PERSONALIZED YOGA THERAPY FOR MULTIPLE SCLEROSIS: EFFECT ON SYMPTOM MANAGEMENT AND QUALITY OF LIFE. THIS STUDY AIMED TO ASSESS THE FEASIBILITY OF PERSONALIZED YOGA THERAPY INTERVENTION IN A PRIVATE SETTING AND ITS EFFECT ON QUALITY OF LIFE (QOL), SLEEP QUALITY, AND SYMPTOM RELIEF AMONG PATIENTS WITH MULTIPLE SCLEROSIS (MS). A SINGLE-GROUP PRE- AND POST-EXPERIMENTAL STUDY WAS CONDUCTED AMONG 10 MEMBERS OF THE MULTIPLE SCLEROSIS SOCIETY OF INDIA BETWEEN DECEMBER 2017 AND APRIL 2018. AT BASELINE AND DURING FOLLOW-UP, QOL, SLEEP QUALITY, SYMPTOMS, AND PAIN WERE ASSESSED USING THE MULTIPLE SCLEROSIS QUALITY OF LIFE, PITTSBURGH SLEEP QUALITY INDEX, MS SYMPTOM CHECKLIST, AND VISUAL ANALOGUE SCALE, RESPECTIVELY. THE INTERVENTION COMPRISED 12 PRIVATE CUSTOMIZED YOGA SESSIONS OF 1 HOUR DURATION AND THREE GROUP SESSIONS, ALL SPREAD OVER 3-MONTHS. PATIENT FEEDBACK AND DIRECT OBSERVATIONS BY THE YOGA THERAPIST WE RE DOCUMENTED AT EACH SESSION. TEN PATIENTS (SEVEN FEMALE, THREE MALE, AGE 31-52 YEARS) WERE ENROLLED IN THE YOGA INTERVENTION; SEVEN COMPLETED 8-12 SESSIONS, AND THREE COMPLETED FEWER THAN 5 SESSIONS. THERAPIST-TO-PATIENT RATIO WAS 1:2. ALL DOMAINS EXCEPT SEXUAL FUNCTION SHOWED CLINICALLY SIGNIFICANT IMPROVEMENT IN QOL SCORES. STATISTICALLY SIGNIFICANT IMPROVEMENT WAS FOUND IN SOCIAL FUNCTION (P = 0.014) AND CHANGE IN HEALTH STATUS (P = 0.029) SCORES AFTER THE INTERVENTION. ALTHOUGH THERE WAS IMPROVEMENT IN PAIN AND SLEEP QUALITY, THESE CHANGES WERE NOT STATISTICALLY SIGNIFICANT. PATIENTS REPORTED IMPROVEMENT IN SYMPTOMS WITH PRACTICE OF YOGA ALONGSIDE LIFESTYLE CHANGES. THE STUDY SUPPORTS THE FEASIBILITY OF THIS 3-MONTH YOGA INTERVENTION FOR PATIENTS WITH MS. STUDIES WITH LARGER SAMPLE SIZES ARE REQUIRED TO CONFIRM OUR FINDINGS. 2021 11 1585 35 MEDICAL YOGA FOR PATIENTS WITH STRESS-RELATED SYMPTOMS AND DIAGNOSES IN PRIMARY HEALTH CARE: A RANDOMIZED CONTROLLED TRIAL. AN INCREASING NUMBER OF PATIENTS ARE SUFFERING FROM STRESS-RELATED SYMPTOMS AND DIAGNOSES. THE PURPOSE OF THIS STUDY WAS TO EVALUATE THE MEDICAL YOGA TREATMENT IN PATIENTS WITH STRESS-RELATED SYMPTOMS AND DIAGNOSES IN PRIMARY HEALTH CARE. A RANDOMIZED CONTROLLED STUDY WAS PERFORMED AT A PRIMARY HEALTH CARE CENTRE IN SWEDEN FROM MARCH TO JUNE, 2011. PATIENTS WERE RANDOMLY ALLOCATED TO A CONTROL GROUP RECEIVING STANDARD CARE OR A YOGA GROUP TREATED WITH MEDICAL YOGA FOR 1 HOUR, ONCE A WEEK, OVER A 12-WEEK PERIOD IN ADDITION TO THE STANDARD CARE. A TOTAL OF 37 MEN AND WOMEN, MEAN AGE OF 53 +/- 12 YEARS WERE INCLUDED. GENERAL STRESS LEVEL (MEASURED USING PERCEIVED STRESS SCALE (PSS)), BURNOUT (SHIROM-MELAMED BURNOUT QUESTIONNAIRE (SMBQ)), ANXIETY AND DEPRESSION (HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)), INSOMNIA SEVERITY (INSOMNIA SEVERITY INDEX (ISI)), PAIN (VISUAL ANALOGUE SCALE (VAS)), AND OVERALL HEALTH STATUS (EURO QUALITY OF LIFE VAS (EQ-VAS)) WERE MEASURED BEFORE AND AFTER 12 WEEKS. PATIENTS ASSIGNED TO THE YOGA GROUP SHOWED SIGNIFICANTLY GREATER IMPROVEMENTS ON MEASURES OF GENERAL STRESS LEVEL (P < 0.000), ANXIETY (P < 0.019), AND OVERALL HEALTH STATUS (P < 0.018) COMPARED TO CONTROLS. TREATMENT WITH MEDICAL YOGA IS EFFECTIVE IN REDUCING LEVELS OF STRESS AND ANXIETY IN PATIENTS WITH STRESS-RELATED SYMPTOMS IN PRIMARY HEALTH CARE. 2013 12 2529 39 YOGA EFFECTIVELY REDUCES FATIGUE AND SYMPTOMS OF DEPRESSION IN PATIENTS WITH DIFFERENT TYPES OF CANCER. PURPOSE: EXAMINE THE EFFECTS OF AN 8-WEEK YOGA THERAPY ON FATIGUE IN PATIENTS WITH DIFFERENT TYPES OF CANCER. METHODS: A TOTAL OF 173 CANCER PATIENTS SUFFERING FROM MILD TO SEVERE FATIGUE WERE RANDOMLY ALLOCATED TO YOGA INTERVENTION (N = 84) (IG) VERSUS WAITLIST CONTROL GROUP (CG) (N = 88). YOGA THERAPY CONSISTED OF EIGHT WEEKLY SESSIONS WITH 60 MIN EACH. THE PRIMARY OUTCOME WAS SELF-REPORTED FATIGUE SYMPTOMS. SECONDARY OUTCOMES WERE SYMPTOMS OF DEPRESSION AND QUALITY OF LIFE (QOL). DATA WERE ASSESSED USING QUESTIONNAIRES BEFORE (T0) AND AFTER YOGA THERAPY FOR IG VERSUS WAITING PERIOD FOR CG (T1). RESULTS: A STRONGER REDUCTION OF GENERAL FATIGUE (P = .033), PHYSICAL FATIGUE (P = .048), AND DEPRESSION (P < .001) AS WELL AS A STRONGER INCREASE IN QOL (P = .002) WAS FOUND FOR PATIENTS WHO ATTENDED 7 OR 8 SESSIONS COMPARED WITH CONTROLS. WITHIN THE YOGA GROUP, BOTH HIGHER ATTENDANCE RATE AND LOWER T0-FATIGUE WERE SIGNIFICANT PREDICTORS OF LOWER T1-FATIGUE (P